ArticleScientific reports2025
Enzyme action optimizer based infinite impulse response filter identification through a comprehensive benchmark across full and reduced orders.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Gudermannian Function-Driven Controller Architecture Optimized by Starfish Optimizer for Superior Transient Performance of Automatic Voltage Regulation.Biomimetics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the nonlinear and multimodal nature of infinite impulse response filter coefficient spaces, achieving stable and accurate identification remains a challenging task in digital signal processing. This study aims to evaluate the capability of the recently developed bio-inspired metaheuristic algorithm, called the enzyme action optimizer, for adaptive identification of infinite impulse response (IIR) filter models with varying structural complexities. The algorithm is tested on four benchmark systems with varying levels of order and structural complexity. For each system, both full-order and reduced-order identification scenarios are examined, resulting in eight independent experiments. In every case, enzyme action optimizer is directly compared with several well-known optimization algorithms including starfish optimization algorithm, hippopotamus optimizer, and grey wolf optimization. The results are evaluated using multiple performance criteria, including mean squared error, mean absolute error, standard deviation, and convergence speed, providing a comprehensive assessment. The results clearly show that enzyme action optimizer provides highly precise identification across all cases. In low-order systems with full-order modelling, the algorithm achieves perfect reconstruction with zero mean squared error, demonstrating its ability to exactly match system dynamics. In reduced-order setups, where structural simplification introduces modelling challenges, enzyme action optimizer consistently delivers the lowest errors and most stable convergence profiles. Even in high-order and asymmetric systems, enzyme action optimizer maintains its advantage, outperforming all comparative methods both in terms of accuracy and convergence speed. The success of enzyme action optimizer stems from its biologically inspired structure, where two control parameters, adaptive factor and enzyme concentration, regulate the balance between exploration and exploitation throughout the optimization process. This dynamic control enables enzyme action optimizer to search broadly in early iterations and focus on fine-tuning in later stages. The study establishes a unified benchmarking framework that uniquely demonstrates how a biologically inspired optimizer can be effectively adapted to complex infinite impulse response identification problems, highlighting its novelty and potential for broader optimization applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.